Where Healthcare Meets Growth
Your Partner for Accelerated Business Transformation
Sheridan is a healthcare-focused private equity firm, bringing sector knowledge with a collaborative and strategic approach to building enduring value.
Raised
Platforms
Add-ons
Organic growth achieved vs. industry average
As of September 30, 2024
The Sheridan Foundation is Built Upon
a Lasting Commitment to Our Partners
Sheridan strives to build enduring value by providing growth-oriented solutions across the healthcare landscape.
Engaged, Thesis-Driven Investors
Utilizing a disciplined and focused approach, we seek to partner with founders and management teams in select healthcare subsectors, leveraging our deep connections and extensive resources to help them grow and optimize their operations for the benefit of patients, clients, and shareholders alike.
Helping Build Exceptional
Healthcare Companies
We empower our partners to achieve their goals and meaningfully scale their companies.
Sheridan helped us grow well beyond our expectations, but they were equally thoughtful about knowing when and how to find the right partner for the next phase of our journey.
Scotte Hudsmith CEO & Chairman | Smile Doctors
We could not be more pleased with the outcome of our partnership with Sheridan. Since the very beginning, the Sheridan team invested in our organization and our people to advance our mission of helping hospitals improve patient care through the delivery of our innovative cost-savings solutions.
Dan Geelhoed CEO & Co-Founder | SpendMend
Our company operates within a highly nuanced framework of agency oversight. Sheridan understood this landscape better than any other group and was able to move quickly and decisively to close our deal.
Michael Blaire CEO & Founder | Diamondback Drugs
Sheridan helped us grow well beyond our expectations, but they were equally thoughtful about knowing when and how to find the right partner for the next phase of our journey.
Scotte Hudsmith CEO & Chairman | Smile Doctors
We could not be more pleased with the outcome of our partnership with Sheridan. Since the very beginning, the Sheridan team invested in our organization and our people to advance our mission of helping hospitals improve patient care through the delivery of our innovative cost-savings solutions.
Dan Geelhoed CEO & Co-Founder | SpendMend
Our company operates within a highly nuanced framework of agency oversight. Sheridan understood this landscape better than any other group and was able to move quickly and decisively to close our deal.
Michael Blaire CEO & Founder | Diamondback Drugs
Committed, Capable, and Friendly Partners
Sheridan’s reputation is founded on working collaboratively as we provide access to our extensive healthcare expertise and network. We pride ourselves on the long-term relationships we build with our partners.
Follow Our Progress
Explore the latest news about our investment activity and portfolio companies.
2025 proved to be a strong year for Sheridan Capital Partners despite market volatility. We remained focused on disciplined growth and value creation across the portfolio, closing on multiple platform and add-on investments, and realizing two successful exits.
AUBURN, N.Y. – January 20, 2026 – Currier Plastics (“Currier”), a manufacturer of custom, precision plastic components used primarily in healthcare and life sciences, and provider of value‑added services including design engineering, material selection, and assembly, today announced the appointment of Steve Bohnet and John Weber to Currier’s Board of Directors.
CHICAGO, IL – January 13, 2026 – Sheridan Capital Partners (“Sheridan”) today announced the completion of its investment in ICANotes (or “the Company”), a Practice Management (“PM”) and Electronic Health Record (“EHR”) software platform purpose-built for the behavioral health market.